Figure 4.
Adhesion of conventional and CXCR5+CD4+T cells to LPS-activated hDMVECs. (A) Human peripheral blood CD4+/CXCR5− (conventional) or CD4+/CXCR5+ (cTf) T cells flow sorted. Equal numbers of CD4+/CXCR5− and CD4+/CXCR5+ T cells were then incubated for 1 hour on hDMVECs that were pretreated for 24 hours with LPS (10 ng/mL) in the absence and presence of 20 μg/mL function-blocking anti-CXCL13 antibody. Samples were then subjected to brief washing with warm media, fixation, staining for CD4, and imaging. (B) Representative fields of view showing phase and fluorescence images overlaid. T cells were labeled with anti-CD4-Alexa488 antibody, shown in green. Scale bar, 20 μm. (C) Quantitation of average number of cells per field of view (10 images per condition for 2 separate experiments).

Adhesion of conventional and CXCR5+CD4+T cells to LPS-activated hDMVECs. (A) Human peripheral blood CD4+/CXCR5 (conventional) or CD4+/CXCR5+ (cTf) T cells flow sorted. Equal numbers of CD4+/CXCR5 and CD4+/CXCR5+ T cells were then incubated for 1 hour on hDMVECs that were pretreated for 24 hours with LPS (10 ng/mL) in the absence and presence of 20 μg/mL function-blocking anti-CXCL13 antibody. Samples were then subjected to brief washing with warm media, fixation, staining for CD4, and imaging. (B) Representative fields of view showing phase and fluorescence images overlaid. T cells were labeled with anti-CD4-Alexa488 antibody, shown in green. Scale bar, 20 μm. (C) Quantitation of average number of cells per field of view (10 images per condition for 2 separate experiments).

Close Modal

or Create an Account

Close Modal
Close Modal